Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Synthesis, physicochemical characterisation and biological activity of anandamide/ɛ-polycaprolactone nanoparticles obtained by electrospraying.

Martín Giménez VM, Russo MG, Narda GE, Fuentes LB, Mazzei L, Gamarra-Luques C, Kassuha DE, Manucha W.

IET Nanobiotechnol. 2020 Feb;14(1):86-93. doi: 10.1049/iet-nbt.2019.0108.

PMID:
31935683
2.

UHPLC-Q/Orbitrap/MS/MS Fingerprinting, Free Radical Scavenging, and Antimicrobial Activity of Tessaria absinthiodes (Hook. & Arn.) DC. (Asteraceae) Lyophilized Decoction from Argentina and Chile.

Gómez J, Simirgiotis MJ, Lima B, Gamarra-Luques C, Bórquez J, Caballero D, Feresin GE, Tapia A.

Antioxidants (Basel). 2019 Nov 28;8(12). pii: E593. doi: 10.3390/antiox8120593.

3.

Antioxidant, Gastroprotective, Cytotoxic Activities and UHPLC PDA-Q Orbitrap Mass Spectrometry Identification of Metabolites in Baccharis grisebachii Decoction.

Gómez J, Simirgiotis MJ, Lima B, Paredes JD, Villegas Gabutti CM, Gamarra-Luques C, Bórquez J, Luna L, Wendel GH, Maria AO, Feresin GE, Tapia A.

Molecules. 2019 Mar 19;24(6). pii: E1085. doi: 10.3390/molecules24061085.

4.

Evaluation of cytotoxic and antitumoral properties of Tessaria absinthioides (Hook & Arn) DC, "pájaro bobo", aqueous extract.

Persia FA, Rinaldini E, Carrión A, Hapon MB, Gamarra-Luques C.

Medicina (B Aires). 2017;77(4):283-290.

5.

Mifepristone increases mRNA translation rate, triggers the unfolded protein response, increases autophagic flux, and kills ovarian cancer cells in combination with proteasome or lysosome inhibitors.

Zhang L, Hapon MB, Goyeneche AA, Srinivasan R, Gamarra-Luques CD, Callegari EA, Drappeau DD, Terpstra EJ, Pan B, Knapp JR, Chien J, Wang X, Eyster KM, Telleria CM.

Mol Oncol. 2016 Aug;10(7):1099-117. doi: 10.1016/j.molonc.2016.05.001. Epub 2016 May 17.

6.

Resistance to cisplatin and paclitaxel does not affect the sensitivity of human ovarian cancer cells to antiprogestin-induced cytotoxicity.

Gamarra-Luques CD, Hapon MB, Goyeneche AA, Telleria CM.

J Ovarian Res. 2014 Apr 27;7:45. doi: 10.1186/1757-2215-7-45. eCollection 2014.

7.

Synergistic lethality of mifepristone and LY294002 in ovarian cancer cells.

Wempe SL, Gamarra-Luques CD, Telleria CM.

Cancer Growth Metastasis. 2013;6:1-13. Epub 2012 Jan 28.

8.

Mifepristone prevents repopulation of ovarian cancer cells escaping cisplatin-paclitaxel therapy.

Gamarra-Luques CD, Goyeneche AA, Hapon MB, Telleria CM.

BMC Cancer. 2012 Jun 22;12:200. doi: 10.1186/1471-2407-12-200.

9.

Short term hypothyroidism affects ovarian function in the cycling rat.

Hapon MB, Gamarra-Luques C, Jahn GA.

Reprod Biol Endocrinol. 2010 Feb 11;8:14. doi: 10.1186/1477-7827-8-14.

Supplemental Content

Loading ...
Support Center